Business Description
MaxCyte Inc
NAICS : 334510
SIC : 3845
ISIN : US57777K1060
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.45 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.43 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 8.3 | |||||
Beneish M-Score | 46.89 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.1 | |||||
3-Year EBITDA Growth Rate | -47.2 | |||||
3-Year EPS without NRI Growth Rate | -32.3 | |||||
3-Year FCF Growth Rate | -18.7 | |||||
3-Year Book Growth Rate | 60 | |||||
Future 3-5Y EPS without NRI Growth Rate | -15.01 | |||||
Future 3-5Y Total Revenue Growth Rate | 16.95 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.59 | |||||
9-Day RSI | 42.97 | |||||
14-Day RSI | 48.09 | |||||
6-1 Month Momentum % | -25.28 | |||||
12-1 Month Momentum % | -12.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 13.26 | |||||
Quick Ratio | 12.37 | |||||
Cash Ratio | 11.69 | |||||
Days Inventory | 830.37 | |||||
Days Sales Outstanding | 61.78 | |||||
Days Payable | 114.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.9 | |||||
Shareholder Yield % | -0.25 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.33 | |||||
Operating Margin % | -107.88 | |||||
Net Margin % | -83.26 | |||||
FCF Margin % | -70.25 | |||||
ROE % | -15.39 | |||||
ROA % | -13.5 | |||||
ROIC % | -69.5 | |||||
ROC (Joel Greenblatt) % | -114.53 | |||||
ROCE % | -18.57 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10.39 | |||||
PB Ratio | 2.05 | |||||
Price-to-Tangible-Book | 2.13 | |||||
EV-to-EBIT | -6.82 | |||||
EV-to-EBITDA | -7.51 | |||||
EV-to-Forward-EBITDA | -10.6 | |||||
EV-to-Revenue | 7.36 | |||||
EV-to-Forward-Revenue | 5.51 | |||||
EV-to-FCF | -10.48 | |||||
Price-to-Projected-FCF | 9.36 | |||||
Price-to-Net-Current-Asset-Value | 3.29 | |||||
Price-to-Net-Cash | 3.84 | |||||
Earnings Yield (Greenblatt) % | -14.66 | |||||
FCF Yield % | -6.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return %
Total Annual Return %
MaxCyte Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 34.931 | ||
EPS (TTM) (£) | -0.279 | ||
Beta | 0.04 | ||
Volatility % | 71.96 | ||
14-Day RSI | 48.09 | ||
14-Day ATR (£) | 0.161624 | ||
20-Day SMA (£) | 3.688 | ||
12-1 Month Momentum % | -12.65 | ||
52-Week Range (£) | 1.8 - 4.3 | ||
Shares Outstanding (Mil) | 104.54 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MaxCyte Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MaxCyte Inc Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
MaxCyte Inc Frequently Asked Questions
What is MaxCyte Inc(LSE:MXCT)'s stock price today?
When is next earnings date of MaxCyte Inc(LSE:MXCT)?
Does MaxCyte Inc(LSE:MXCT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |